Literature DB >> 11955436

Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.

Chunming Liu1, Yiming Li, Mikhail Semenov, Chun Han, Gyeong Hun Baeg, Yi Tan, Zhuohua Zhang, Xinhua Lin, Xi He.   

Abstract

Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC). Here we describe another Axin-associated kinase, whose phosphorylation of beta-catenin precedes and is required for subsequent GSK-3 phosphorylation of beta-catenin. This "priming" kinase is casein kinase Ialpha (CKIalpha). Depletion of CKIalpha inhibits beta-catenin phosphorylation and degradation and causes abnormal embryogenesis associated with excessive Wnt/beta-catenin signaling. Our study uncovers distinct roles and steps of beta-catenin phosphorylation, identifies CKIalpha as a component in Wnt/beta-catenin signaling, and has implications to pathogenesis/therapeutics of human cancers and diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955436     DOI: 10.1016/s0092-8674(02)00685-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  827 in total

Review 1.  T-cell factors: turn-ons and turn-offs.

Authors:  Adam Hurlstone; Hans Clevers
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

Review 2.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

3.  mrhl RNA, a long noncoding RNA, negatively regulates Wnt signaling through its protein partner Ddx5/p68 in mouse spermatogonial cells.

Authors:  Gayatri Arun; Vijay Suresh Akhade; Sainitin Donakonda; Manchanahalli R Satyanarayana Rao
Journal:  Mol Cell Biol       Date:  2012-06-04       Impact factor: 4.272

4.  Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease.

Authors:  Juliette D Godin; Ghislaine Poizat; Miriam A Hickey; Florence Maschat; Sandrine Humbert
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

Review 5.  High-throughput screening strategies for targeted identification of therapeutic compounds in colorectal cancer.

Authors:  Agnieszka B Bialkowska; Vincent W Yang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

6.  Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta -catenin-regulated cell proliferation.

Authors:  Guangnan Li; Ravi Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

7.  SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.

Authors:  Jianping Jin; Takahiro Shirogane; Lai Xu; Grzegorz Nalepa; Jun Qin; Stephen J Elledge; J Wade Harper
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

Review 8.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

9.  Tyrosine phosphorylation of plakoglobin causes contrary effects on its association with desmosomes and adherens junction components and modulates beta-catenin-mediated transcription.

Authors:  Susana Miravet; José Piedra; Julio Castaño; Imma Raurell; Clara Francí; Mireia Duñach; Antonio García de Herreros
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Molecular control of the oocyte to embryo transition.

Authors:  Barbara B Knowles; Alexei V Evsikov; Wilhelmine N de Vries; Anne E Peaston; Davor Solter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-08-29       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.